• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Gains Over 50 Points; Nippon Steel To Acquire U. S. Steel

    12/18/23 9:51:14 AM ET
    $BMRA
    $CKPT
    $CUEN
    $GPCR
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $BMRA alert in real time by email

    U.S. stocks traded higher this morning, with the Dow Jones index gaining around 50 points on Monday.

    Following the market opening Monday, the Dow traded up 0.15% to 37,362.28 while the NASDAQ rose 0.14% to 14,835.17. The S&P 500 also rose, gaining, 0.29% to 4,732.84.

    Check This Out: Snap To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Monday

     

    Leading and Lagging Sectors

     

    Energy shares rose by 1.8% on Monday.

    In trading on Monday, information technology shares fell by 0.3%.

     

    Top Headline

     

    Nippon Steel Corp (OTC:NISTF) announced plans to acquire United States Steel Corp (NYSE:X) for $14.1 billion-plus debt, with a total enterprise value of $14.9 billion.

    The acquisition price of $55.00 per share represents a 40% premium to X's closing stock price on Dec. 15, 2023.

     

    Equities Trading UP

     

    iCoreConnect Inc. (NASDAQ:ICCT) shares shot up 81% to $3.0699 after surging over 73% on Friday.

    Shares of Biomerica, Inc. (NASDAQ:BMRA) got a boost, surging 59% to $1.5715. Biomerica received FDA 510(k) clearance for its Hp Detect Stool Antigen ELISA test, designed to detect the presence of the H. pylori bacteria.

    Cuentas Inc. (NASDAQ:CUEN) shares were also up, gaining 43% to $1.97.

     

    Equities Trading DOWN

     

    Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) shares dropped 57% to $1.43. The FDA has issued a Complete Response letter to Checkpoint Therapeutics' Cosibelimab Biologic License Application for metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or radiation.

    Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) were down 52% to $28.34 after the company announced a comprehensive development program update for GSBR-1290.

    Minerva Surgical, Inc. (NASDAQ:UTRS) was down, falling 51% to $1.3799. On Dec. 15, 2023, Minerva Surgical notified the Nasdaq of its intent to file a Form 25 with the SEC on or about Dec. 26, 2023 to effect the voluntary delisting of the company's common stock from Nasdaq.

    Also Check This Out: How To Earn $500 A Month From Darden Restaurants Stock Following Upbeat Earnings

     

    Commodities

     

    In commodity news, oil traded up 2.8% to $73.43 while gold traded up 0.1% at $2,036.90.

    Silver traded up 0.1% to $24.185 on Monday while copper fell 0.5% to $3.8725.

     

    Euro zone

     

    European shares were mostly lower today. The eurozone’s STOXX 600 slipped 0.1%, London’s FTSE 100 gained 0.6% while Spain’s IBEX 35 Index fell 0.1% The German DAX fell 0.4% French CAC 40 fell 0.4%, while Italy’s FTSE MIB Index fell 0.3%.

    The Ifo Business Climate indicator for Germany fell to a three-month low level of 86.4 in December versus a revised reading of 87.2 in November.

     

    Asia Pacific Markets

     

    Asian markets closed mixed on Monday, with Japan’s Nikkei 225 falling 0.64%, Hong Kong’s Hang Seng Index declining 0.97% and China’s Shanghai Composite Index falling 0.40%. India’s S&P BSE Sensex, meanwhile, fell 0.24%.

    Singapore's non-oil domestic exports rose by 1% year-over-year in November compared to a revised 3.5% decline in October.

     

    Economics

     

    The housing market index will be released at 10:00 a.m. ET.

    Now Read This: Top 3 Health Care Stocks That Are Preparing To Pump This Month

     

    Get the next $BMRA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BMRA
    $CKPT
    $CUEN
    $GPCR

    CompanyDatePrice TargetRatingAnalyst
    United States Steel Corporation
    $X
    5/27/2025$55.00Buy → Hold
    Jefferies
    United States Steel Corporation
    $X
    5/27/2025Outperform → Peer Perform
    Wolfe Research
    Structure Therapeutics Inc.
    $GPCR
    5/2/2025$60.00Buy
    Citigroup
    United States Steel Corporation
    $X
    4/16/2025$38.00Overweight → Neutral
    Analyst
    United States Steel Corporation
    $X
    3/31/2025$45.00Outperform → Market Perform
    BMO Capital Markets
    Structure Therapeutics Inc.
    $GPCR
    2/28/2025Outperform
    William Blair
    United States Steel Corporation
    $X
    2/3/2025$39.00 → $39.00Overweight → Equal-Weight
    Morgan Stanley
    Checkpoint Therapeutics Inc.
    $CKPT
    1/13/2025$9.00Buy
    D. Boral Capital
    More analyst ratings

    $BMRA
    $CKPT
    $CUEN
    $GPCR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Chin Eric was granted 22,500 shares, increasing direct ownership by 225% to 32,500 units (SEC Form 4)

    4 - BIOMERICA INC (0000073290) (Issuer)

    1/28/26 5:40:25 PM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form 4 filed by See Remark 1 Fmr Llc

    4 - Structure Therapeutics Inc. (0001888886) (Issuer)

    1/20/26 9:22:14 AM ET
    $GPCR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Lu Gary was granted 40,000 shares, increasing direct ownership by 206% to 59,375 units (SEC Form 4)

    4 - BIOMERICA INC (0000073290) (Issuer)

    12/31/25 5:10:08 PM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $BMRA
    $CKPT
    $CUEN
    $GPCR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    World Mobile Group Ltd Converts Payable Notes Into Equity, Acquiring Approximately 18.5% of Cuentas Inc. and Deepening a High-Growth Strategic Alliance

    Miami Beach, FL and London, UK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Cuentas Inc. (OTCQB:CUEN) and World Mobile Group Ltd today announced a transformative equity transaction in which World Mobile Group Ltd exercised its payable notes in exchange for 1,277,018 shares of common stock of Cuentas Inc., representing approximately 18.5% ownership of the Company. This strategic conversion signals a strong vote of confidence in Cuentas' platform and accelerates the companies' shared mission to build a next-generation mobile, blockchain, and media ecosystem. Cuentas Inc. and World Mobile Group Ltd. (UK) jointly own World Mobile LLC. World Mobile Group Ltd. owns and manages the rapidly expanding WMTx

    2/25/26 9:00:00 AM ET
    $CUEN
    Computer Software: Prepackaged Software
    Technology

    Vietnam Approves Biomerica's EZ Detect™ for Nationwide Distribution

    Approval Marks Biomerica's Strategic Entry into Southeast Asia's Rapidly Growing Healthcare MarketSimple, FDA-Cleared At-Home Test Detects an Early Warning Sign of Colorectal Cancer in Minutes IRVINE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ:BMRA), a global provider of advanced diagnostic solutions, announced that Vietnam's Hanoi Department of Health has officially approved the EZ Detect™ colorectal disease at-home screening test for sales and distribution throughout Vietnam. Biomerica is working with a major healthcare products distributor in Vietnam who will manage the sales and distribution of the product through pharmacies, hospitals, physician's offices, and

    2/18/26 8:19:00 AM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Cuentas Extends Expiration Date of its Publicly Traded Warrants From February 4, 2026 to June 30, 2026

    MIAMI BEACH, FL, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Cuentas, Inc. (OTCID: CUEN & CUENW) ("Cuentas") Cuentas, Inc. (the "Company") today announced that it had extended the expiration date of its publicly traded warrants (OTCID: CUENW) (the "Warrants") from February 4, 2026 to June 30, 2026. The Warrants were issued and sold by the Company on February 4, 2021 as part of a firm commitment public offering of its units, consisting of one share of its common stock, par value $0.001 per share ("Common Stock"), and a warrant to purchase an additional share of Common Stock exercisable for five years at an exercise price of $4.30 per share (the "Warrants"). The Company sold an aggregate of 2,790,6

    2/4/26 8:26:00 AM ET
    $CUEN
    Computer Software: Prepackaged Software
    Technology

    $BMRA
    $CKPT
    $CUEN
    $GPCR
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Structure Therapeutics Inc.

    SCHEDULE 13G/A - Structure Therapeutics Inc. (0001888886) (Subject)

    2/17/26 4:18:12 PM ET
    $GPCR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Structure Therapeutics Inc.

    SCHEDULE 13G/A - Structure Therapeutics Inc. (0001888886) (Subject)

    2/13/26 8:46:14 AM ET
    $GPCR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Structure Therapeutics Inc.

    SCHEDULE 13G/A - Structure Therapeutics Inc. (0001888886) (Subject)

    2/10/26 11:23:20 AM ET
    $GPCR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMRA
    $CKPT
    $CUEN
    $GPCR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    U.S. Steel downgraded by Jefferies with a new price target

    Jefferies downgraded U.S. Steel from Buy to Hold and set a new price target of $55.00

    5/27/25 9:09:57 AM ET
    $X
    Steel/Iron Ore
    Industrials

    U.S. Steel downgraded by Wolfe Research

    Wolfe Research downgraded U.S. Steel from Outperform to Peer Perform

    5/27/25 9:09:57 AM ET
    $X
    Steel/Iron Ore
    Industrials

    Citigroup initiated coverage on Structure Therapeutics with a new price target

    Citigroup initiated coverage of Structure Therapeutics with a rating of Buy and set a new price target of $60.00

    5/2/25 8:15:19 AM ET
    $GPCR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMRA
    $CKPT
    $CUEN
    $GPCR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Schonfeld Strategic Advisors Llc sold $79,589 worth of shares (41,400 units at $1.92) and bought $372,143 worth of shares (146,800 units at $2.54) (SEC Form 4)

    4 - iCoreConnect Inc. (0001906133) (Issuer)

    4/28/25 6:12:27 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Director Pasqual John was granted 137,255 shares and bought $2,900 worth of shares (5,000 units at $0.58), increasing direct ownership by 250% to 199,159 units (SEC Form 4)

    4 - iCoreConnect Inc. (0001906133) (Issuer)

    12/9/24 5:00:42 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Mcdermott Robert P was granted 152,893 shares and bought $49,421 worth of shares (276,785 units at $0.18), increasing direct ownership by 51% to 1,269,885 units (SEC Form 4)

    4 - iCoreConnect Inc. (0001906133) (Issuer)

    12/6/24 5:00:15 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    $BMRA
    $CKPT
    $CUEN
    $GPCR
    Leadership Updates

    Live Leadership Updates

    View All

    Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors

    Brings decades of leadership in laboratory testing, clinical diagnostics, payor strategy, and sales growth Extensive track record in commercializing advanced laboratory testing and insurer strategies IRVINE, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ:BMRA), a global provider of advanced diagnostic solutions, today announced the appointment of Gary Huff to its Board of Directors as an independent board member. Mr. Huff brings decades of leadership experience in the diagnostics and healthcare services industry, including serving as Chief Executive Officer of LabCorp Diagnostics, one of the world's largest clinical laboratories. Mr. Huff is a hands-on, inspirational,

    10/8/25 8:19:00 AM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial Officer

    Brings 20+ years of revenue growth leadership in laboratory testing, clinical diagnostics and global expansionLed successful organizational turnarounds and growth strategies at both Boston Heart Diagnostics and Genova DiagnosticsExtensive track record in commercializing advanced laboratory testing, driving growth and payer strategies IRVINE, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ:BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appointment of Scott Madel as Chief Commercial Officer. Scott brings more than two decades of cross-functional expertise in healthcare, diagnostics, commercialization, and pa

    6/26/25 8:19:00 AM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    APi Group Set to Join S&P MidCap 400

    NEW YORK, June 18, 2025 /PRNewswire/ -- APi Group Corp. (NYSE:APG) will replace United States Steel Corp. (NYSE:X) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, June 24. Nippon Steel Corp. (TSE: 5401) acquired United States Steel in a deal that closed today. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date  Index Name  Action  Company Name  Ticker  GICS Sector   June 24, 2025   S&P MidCap 400  Addition  APi Group   APG  Industrials   June 24, 2025   S&P MidCap 400  Deletion  United States Steel  X  Materials  For more information about S&P Dow Jones Indices, please visit www.spdji.com

    6/18/25 5:46:00 PM ET
    $APG
    $SPGI
    $X
    Engineering & Construction
    Consumer Discretionary
    Finance: Consumer Services
    Finance

    $BMRA
    $CKPT
    $CUEN
    $GPCR
    Financials

    Live finance-specific insights

    View All

    Structure Therapeutics Reports Positive Topline Data from ACCESS Program for its Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron

    Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation  Placebo-adjusted mean weight loss up to 15.3% (35.5 lbs) observed with 240 mg dose in the exploratory ACCESS II study at 36 weeks No adverse event-related treatment discontinuations observed when starting at lower 2.5 mg dose in ACCESS Open Label Extension and Body Composition Study Data comprehensively support and inform advancement to Phase 3 clinical development program in mid-2026 Company to host conference call today at 8:30 a.m. Eastern Time SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutic

    12/8/25 8:00:00 AM ET
    $GPCR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Structure Therapeutics to Report Data from ACCESS Clinical Program of Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron, on December 8, 2025

    SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ:GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced plans to release topline data from its ACCESS clinical program of aleniglipron, the company's once-daily oral small molecule GLP-1 receptor agonist for the treatment of obesity, before the market opens on Monday, December 8, 2025. Members of management will host a conference call and webcast to discuss the data at 8:30 a.m. ET the same day. To access the live webcast, please visit the Investor Relations page of the company's website at

    12/7/25 6:20:23 PM ET
    $GPCR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates

    UNLOXCYT™ (cosibelimab-ipdl) approved by U.S. FDA in December 2024 as first and only anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma Special meeting of stockholders to vote on Merger to take place on May 28, 2025 WALTHAM, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced financial results for the first quarter ended March 31, 2025, and recent corporate updates. Recent Corporate Updates: In December 2024, Checkpoint announced that the U.S. Food and Drug Administration ("FDA") approved UNLOXCYT™ (cosibelimab-ipdl) for the tr

    5/13/25 4:15:51 PM ET
    $CKPT
    $FBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMRA
    $CKPT
    $CUEN
    $GPCR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/12/24 9:44:00 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/5/24 4:08:58 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Structure Therapeutics Inc.

    SC 13G/A - Structure Therapeutics Inc. (0001888886) (Subject)

    11/14/24 5:46:12 PM ET
    $GPCR
    Biotechnology: Pharmaceutical Preparations
    Health Care